Sarah Baatout

Person

Baatout, Sarah

  • Radiobiology

Person: Employee

  1. Gallium-68-labelled NOTA-oligonucleotides - an optimized method for their preparation

    Gijs, M., Dammicco, S., Warnier, C., Aerts, A., Impens, N., D’Huyvetter, M., Léonard, M., Baatout, S. & Luxen, A., 1 Feb 2016, In: Journal of Labelled Compounds and Radiopharmaceuticals. 59, 2, p. 63-71 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer

    Gijs, M., Penner, G., Blackler, G. B., Impens, N., Baatout, S., Luxen, A. & Aerts, A., 15 May 2016, In: Pharmaceuticals. 9, 2, 29.

    Research output: Contribution to journalArticlepeer-review

  3. Aptamers as radiopharmaceuticals for nuclear imaging and therapy

    Gijs, M., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 15 Apr 2016, In: Nuclear Medicine and Biology.

    Research output: Contribution to journalArticlepeer-review

  4. Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice

    Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 11 Aug 2016, In: Journal of Nuclear Medicine and Radiation Therapy. 7, 5, 8 p., 1000300.

    Research output: Contribution to journalArticlepeer-review

  5. Radiation-induced double strand breaks and subsequent apoptotic DNA fragmentation in human peripheral blood mononuclear cells

    Ghardi, M., Moreels, M., Chatelain, B., Chatelain, C. & Baatout, S., 1 Jan 2012, In: International Journal of Molecular Medicine. 29, 5, p. 769-780

    Research output: Contribution to journalArticlepeer-review

  6. Iodine deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a VEGF-HIF-1, but not a ROS dependent pathway.

    Gérard, A-C., Humblet, K., Wilvers, C., Poncin, S., Derradji, H., de Ville de Goyet, C., Abouelaradat, K., Baatout, S., Sonveaux, P., Denef, J. F. & Colin, I. M., Jul 2012, In: Thyroid. 22, 7, p. 699-708

    Research output: Contribution to journalArticlepeer-review

  7. Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumour

    Geenen, L., Nonnekens, J., Konijnenberg, M. W., Baatout, S., de Jong, M. & Aerts, A., 1 Nov 2021, In: Nuclear Medicine and Biology. 102-103, p. 1-11 11 p.

    Research output: Contribution to journalArticlepeer-review

  8. Immunological Changes During Space Travel: A Ground-Based Evaluation of the Impact of Neutron Dose Rate on Plasma Cytokine Levels in Human Whole Blood Cultures

    Fisher, R., Baselet, B., Vermeesen, R., Moreels, M., Baatout, S., Rahiman, F., Miles, X., Nair, S., du Plessis, P., Engelbrecht, M., Ndimba, R. J., Bolcaen, X., Nieto-Camero, J., de Kock, E. A. & Vandevoorde, C., 30 Sep 2020, In: Frontiers in Physics. p. 1-12 12 p., 568124.

    Research output: Contribution to journalArticlepeer-review

  9. Gold nanoparticles coated with antibodies lead to ROSdependent apoptotic cell death in non-cancerous human cell lines

    Fichera, O., Van Hoecke, K., Baatout, S., Cardinaels, T., Michiels, C., Lucas, S. & Aerts, A., 31 Dec 2018, Annual Congress of the European Association of Nuclear Medicine October 13 – 17, 2018 Düsseldorf, Germany. Vol. 45. p. S653 1 p. (European Journal of Nuclear Medicine and Molecular Imaging).

    Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

ID: 26770